NCT01266876 Study of the Safety and Efficacy of REGN727/SAR236553 in Patients With HeFH Hypercholesterolemia Status COMPLETED Phase PHASE2
NCT01259323 Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT01249664 VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV) Status COMPLETED Phase PHASE3
NCT01239017 A Study of the Safety and Efficacy of Subcutaneously Administered REGN475 in Patients With Osteoarthritis of the Knee Status WITHDRAWN Phase PHASE2
NCT01217814 Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers Status TERMINATED Phase PHASE2
NCT01209793 Safety and Tolerability Study of REGN846 (SAR302352) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01197391 Ascending Dose Study of the Safety and Tolerability of REGN728 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01161082 Ascending Multi-dose Study of REGN727(SAR236553) With and Without Concomitant Atorvastatin Status COMPLETED Phase PHASE1
NCT01148615 A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT01146652 Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND) Status COMPLETED Phase PHASE3
NCT01118728 Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis Status TERMINATED Phase PHASE2
NCT01074372 Ascending Dose Study of the Safety and Tolerability of REGN727 (SAR236553) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01061736 Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients Status COMPLETED Phase PHASE2/PHASE3
NCT01061723 Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis Status COMPLETED Phase PHASE2
NCT01055899 Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01053702 Study of the Safety and Efficacy of REGN475(SAR164877) in Patients With Pain Resulting From Thermal Injury Status WITHDRAWN Phase PHASE2
NCT01026597 Ascending Dose Study of the Safety and Tolerability of REGN727(SAR236553) in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01026519 A Safety and Tolerability Study of REGN88(SAR153191) in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01015027 Ascending Dose Study of the Safety and Tolerability of REGN668(SAR231893) in Normal Healthy Volunteers Status COMPLETED Phase PHASE1